Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer

2023-03-17T08:33:50-04:00March 16th, 2023|

Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men. "Health Canada has [...]

Telix and Isologic sign License and Distribution Agreement for Illuccix® for Canada

2022-11-27T14:04:02-05:00June 22nd, 2022|

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. Please follow the link [...]


2022-11-27T14:04:02-05:00May 30th, 2019|

Invitation Special invitation, Monday June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents. ****First come first serve**** View invitation [...]

First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada

2022-11-27T14:41:51-05:00March 1st, 2018|

PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC Innovative Radiopharmaceuticals for [...]

IRE-ELiT S.A. & Isologic Sign Exclusive Agreement

2018-04-05T16:11:22-04:00January 31st, 2018|

IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian leader in radiopharmacy servicess [...]

ISOLOGIC Acquires Lantheus Canadian Imaging Centres

2022-11-27T14:58:05-05:00January 14th, 2016|

ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution business operations of Lantheus [...]

Piramal Announces Strategic Partnership with ISOLOGIC

2018-04-05T16:14:07-04:00June 4th, 2015|

PIRAMAL IMAGING ANNOUNCES STRATEGIC PARTNERSHIP WITH ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS FOR EXCLUSIVE COMMERCIALIZATION OF NEURACEQ IN CANADA BOSTON, June 4, 2015 Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce the companies have entered into a strategic partnership and licensing agreement to provide ISOLOGIC with exclusive [...]

Canadian Radiopharmacy Acquisitions

2022-11-27T15:11:11-05:00March 24th, 2014|

PHARMALOGIC P.E.T. SERVICES OF MONTREAL COMPANY AND CARDINAL HEALTH CANADIAN RADIOPHARMACY ACQUISITIONS March 24th, 2014 IsoLogic is proud to announce that following the acquisitions of Pharmalogic P.E.T. Services of Montreal and Cardinal Health’s Ontario based radiopharmacies, it will operate the combined businesses as IsoLogic Innovative [...]

Go to Top